GERN FY 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+32386.9% YoY

Gross Profit

$76M98.4% margin

Operating Income

-$174M-225.6% margin

Net Income

-$175M-226.7% margin

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

-$219M

Free Cash Flow

-$219M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$594M

Total Liabilities

$313M

Stockholders' Equity

$280M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$237,000	+32386.9%
Gross Profit	$76M	$237,000	+31857.0%
Operating Income	-$174M	-$194M	+10.4%
Net Income	-$175M	-$184M	+5.2%